Le Lézard
Classified in: Business
Subject: MERGERS AND ACQUISITIONS (M&A)

James River Completes Sale of Casualty Reinsurance Business to Fleming Holdings


PEMBROKE, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Fleming Intermediate Holdings ("Fleming") has completed its acquisition of JRG Reinsurance Company, Ltd. ("JRG Re") at the previously agreed upon terms.

Frank D'Orazio, the Company's Chief Executive Officer, commented, "We are pleased to have successfully completed our sale of JRG Re to Fleming in accordance with the Stock Purchase Agreement that the parties negotiated together and executed on November 8, 2023. James River will continue to focus its resources on its core U.S. insurance businesses where we have meaningful scale, including our E&S and fronting businesses."

About James River Group Holdings, Ltd.

James River Group Holdings, Ltd. is a Bermuda-based insurance holding company that owns and operates a group of specialty insurance companies. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance. Each of the Company's regulated U.S. insurance subsidiaries are rated "A-" (Excellent) by A.M. Best Company. Visit James River Group Holdings, Ltd. on the web at www.jrvrgroup.com.

James River Investor Contact:
Brett Shirreffs
SVP, Finance, Investments and Investor Relations
+1-919-980-0524
[email protected]

James River Media Contact:
Adam Pollack / Kaitlin Kikalo / Michael Reilly
Joele Frank, Wilkinson Brimmer Katcher
+1-212-355-4449

Forward-Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding the intent, belief or current expectations of James River and its management team, and may be identified by terms such as believe, expect, seek, may, will, intend, project, anticipate, plan, estimate or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Although it is not possible to identify all of these risks and uncertainties, they include, among others, the ongoing litigation between the Company and Fleming Intermediate Holdings and the inherent uncertainty thereof. Additional information about these risks and uncertainties, as well as others that may cause actual results to differ materially from those in the forward-looking statements, is contained in our filings with the U.S. Securities and Exchange Commission ("SEC"), including our most recently filed Annual Report on Form 10-K. These forward-looking statements speak only as of the date of this release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.



These press releases may also interest you

at 03:40
HTA Group, Ltd (the "Offeror"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the launch of its offer to purchase for cash any and all of the 7.000% Senior...

at 03:20
In a grand ceremony held on Wednesday in the Russian Embassy in Beijing, two sculptures portraying the renowned Russian novelist Maxim Gorky (1868-1936) and his Chinese counterpart Lu Xun (1881-1936), who was the most influential representative of...

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 03:00
KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today released its report on cyber threats faced by the financial sector in the UK. The report examines the escalating rise of cyberattacks on...

at 02:46
OKX, a leading Web3 technology company, has issued updates for May 20, 2024. OKX DEX Incorporates ChangeNOW's Cross-Chain Bridges:...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: